Iliac Stents Market

Iliac Stents Market Size

Iliac Stents Market size was valued at around USD 899.9 million in 2023 and is expected to grow at a CAGR of 5% between 2024 and 2032. The increasing prevalence of peripheral artery disease (PAD) is anticipated to be among the primary factors to fuel the market growth.

The increasing prevalence of peripheral artery disease (PAD) is contributing to the growing demand for iliac stents. As the population ages and risk factors such as diabetes, obesity, and smoking become more prevalent, the incidence of PAD is on the rise. More people are experiencing symptoms related to PAD, such as leg pain, cramping, and difficulty walking, which can significantly impact their quality of life.

For instance, according to the Centers for Disease Control and Prevention (CDC), the number of people affected by peripheral artery disease (PAD) in the U.S. is approximately 6.5 million people aged 40 and older. This condition primarily affects African American individuals, with similar or slightly higher rates for Hispanics compared to non-Hispanic white people. This rising prevalence of PAD necessitates highly accurate treatment procedures and related devices, thereby anticipating an increasing demand for iliac stents.

Iliac stents are medical devices used to treat blockages or narrowing (stenosis) in the iliac arteries, which are located in the pelvis and supply blood to the legs. The iliac stent is a small, mesh-like tube made of metal, usually stainless steel or nitinol that is inserted into the narrowed artery to hold it open.

Iliac Stents Market Trends

Recent advancements in iliac stent design and materials have been focused on enhancing efficiency and effectiveness. These advancements include the use of innovative technologies in the development of materials and production techniques that played a significant role in improving stent design, with a focus on optimizing geometric properties such as length, thickness, and scaffold design for better performance.

• Iliac stent design and materials have been driven by innovative technologies and materials to enhance their performance. One notable advancement is the use of four-dimensional (4D) printing technology to create dynamic stents, allowing for more tailored and efficient solutions. This technology enables the fabrication of stents with improved geometric properties and scaffold designs, optimizing their effectiveness in treating vascular conditions, thus expected to fuel their demand in the market.
  
• Furthermore, the development of drug-eluting stents has significantly impacted the field by reducing restenosis rates and improving patient outcomes. These stents are designed to release medication over time, preventing the re-narrowing of the arteries after stent placement. Such technological advancement are increasing the advantages associated with iliac stents and anticipating their increased market progress.
  

Iliac Stents Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on type, the market is segmented into self-expandable stents, balloon-expandable stents, and covered stents. The balloon-expandable stents segment is anticipated to witness the fastest growth rate with a CAGR of 5.2% over the forecast period.

• Physician preference plays a significant role in device selection and adoption. Some interventional cardiologists and vascular surgeons may prefer balloon-expandable stents due to their familiarity with the deployment technique and perceived ease of use compared to other type of stents, is anticipated to boost the segment expansion.  
  
• Moreover, balloon-expandable stents are often made of durable materials, such as stainless steel or cobalt-chromium alloys, which provide long-term support to the vessel. This durability helps prevent stent collapse or migration over time, reducing the need for repeat interventions and the increase in demand.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on artery lesions, the iliac stents market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. The common iliac artery lesions segment was valued at USD 563.3 million in 2023.

• Risk factors for iliac artery lesions, such as diabetes, obesity, hypertension, and smoking, are becoming more prevalent worldwide. These risk factors accelerate the development and progression of atherosclerosis, which may result in a greater number of individuals requiring treatment for iliac artery lesions.
  
• Moreover, the development of minimally invasive endovascular procedures, such as angioplasty and stenting, has revolutionized the treatment of iliac artery lesions. This increase in the adoption of minimally invasive techniques contributing to the growing demand for interventions targeting iliac artery lesions.  
  

The iliac stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospital segment dominates the market with the revenue around USD 512.7 million in 2023.

• Hospitals typically have specialized departments or units dedicated to interventional cardiology, vascular surgery, or interventional radiology. These departments are staffed with skilled healthcare professionals, including cardiologists, vascular surgeons, and radiologists, who have the expertise to diagnose and treat conditions such as peripheral artery disease (PAD) requiring iliac stenting, making hospitals the primary end user.
  
• Moreover, hospitals, with their access to a wide range of resources, including medical supplies, medications, and support staff, are well-equipped to facilitate the successful execution of iliac stenting procedures. This increased accessibility may position them as the key end users of iliac stents.
  

Looking for region specific data?

Download Free PDF

North America iliac stents market accounted for USD 216.8 million revenue in 2023 and is predicted to witness substantial market growth.

• Increasing awareness among patients and healthcare providers about vascular diseases and available treatment options, leading to earlier diagnosis and intervention. Patient education initiatives promote proactive management of vascular conditions, further contributing to the growing demand for iliac stents in North America.
  
• Furthermore, strong clinical evidence supporting the efficacy and safety of iliac stenting, along with clinical practice guidelines recommending endovascular interventions for iliac artery lesions, influence clinical decision-making and drive the demand for these procedures in the region.
  

Iliac Stents Market Share

The iliac stents industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.

Iliac Stents Market Companies

Some of the eminent market participants operating in the iliac stents industry include:

• Abbott Laboratories
• Alvimedica
• Becton, Dickinson and Company
• Biotronik
• Boston Scientific Corporation
• B. Braun SE
• Cook
• Getinge AB
• iVascular
• Medtronic Plc
  

Iliac Stents Industry News

• In March 2024, Becton, Dickinson and Company initiated an international study to expand treatment options for patients with peripheral arterial disease (PAD). The study aims to assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of PAD. This initiative may enhance the company’s reach and may enhance its position in the iliac market.
  
• In May 2021, Alvimedica announced the CE mark approval of the new polymer-free self-expanding Amphilimus eluting DES for SFA lesions, NiTiDES. This approval improved the company’s reputation in the market and enabled increased customer base.
  

Iliac stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Self-expandable stents
• Balloon-expandable stents
• Covered stents

Market, By Artery Lesions

• Common iliac artery lesions
• Severe calcified lesions
• Complete obstructive lesions

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa